Cargando…
Comment on: ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705879/ https://www.ncbi.nlm.nih.gov/pubmed/26372699 http://dx.doi.org/10.1038/bjc.2015.331 |
_version_ | 1782409095646543872 |
---|---|
author | Cardillo, Giuseppe Mokhles, Sahar Williams, Norman Macbeth, Fergus Russell, Christopher Treasure, Tom |
author_facet | Cardillo, Giuseppe Mokhles, Sahar Williams, Norman Macbeth, Fergus Russell, Christopher Treasure, Tom |
author_sort | Cardillo, Giuseppe |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4705879 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-47058792016-01-27 Comment on: ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy Cardillo, Giuseppe Mokhles, Sahar Williams, Norman Macbeth, Fergus Russell, Christopher Treasure, Tom Br J Cancer Letter to the Editor Nature Publishing Group 2015-12-01 2015-09-15 /pmc/articles/PMC4705879/ /pubmed/26372699 http://dx.doi.org/10.1038/bjc.2015.331 Text en Copyright © 2015 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ This work is licensed under the Creative Commons Attribution-Non-Commercial-Share Alike 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ |
spellingShingle | Letter to the Editor Cardillo, Giuseppe Mokhles, Sahar Williams, Norman Macbeth, Fergus Russell, Christopher Treasure, Tom Comment on: ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy |
title | Comment on: ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy |
title_full | Comment on: ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy |
title_fullStr | Comment on: ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy |
title_full_unstemmed | Comment on: ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy |
title_short | Comment on: ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy |
title_sort | comment on: ‘kras and braf mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705879/ https://www.ncbi.nlm.nih.gov/pubmed/26372699 http://dx.doi.org/10.1038/bjc.2015.331 |
work_keys_str_mv | AT cardillogiuseppe commentonkrasandbrafmutationsareprognosticbiomarkersinpatientsundergoinglungmetastasectomyofcolorectalcancervariationinsurvivalassociatedwithprotooncongenesisnotevidenceforeffectivenessoflungmetastasectomy AT mokhlessahar commentonkrasandbrafmutationsareprognosticbiomarkersinpatientsundergoinglungmetastasectomyofcolorectalcancervariationinsurvivalassociatedwithprotooncongenesisnotevidenceforeffectivenessoflungmetastasectomy AT williamsnorman commentonkrasandbrafmutationsareprognosticbiomarkersinpatientsundergoinglungmetastasectomyofcolorectalcancervariationinsurvivalassociatedwithprotooncongenesisnotevidenceforeffectivenessoflungmetastasectomy AT macbethfergus commentonkrasandbrafmutationsareprognosticbiomarkersinpatientsundergoinglungmetastasectomyofcolorectalcancervariationinsurvivalassociatedwithprotooncongenesisnotevidenceforeffectivenessoflungmetastasectomy AT russellchristopher commentonkrasandbrafmutationsareprognosticbiomarkersinpatientsundergoinglungmetastasectomyofcolorectalcancervariationinsurvivalassociatedwithprotooncongenesisnotevidenceforeffectivenessoflungmetastasectomy AT treasuretom commentonkrasandbrafmutationsareprognosticbiomarkersinpatientsundergoinglungmetastasectomyofcolorectalcancervariationinsurvivalassociatedwithprotooncongenesisnotevidenceforeffectivenessoflungmetastasectomy |